Loading...
Ifosfamide — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Ifosfamide
2025-Q4
Comprehensive analysis of India’s ifosfamide export trade — suppliers, buyers, prices, routes, and every shipment record.
63
Shipments
$123K
Trade Value
33
Suppliers
28
Buyers
30
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/ifosfamide
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s ifosfamide trade — 2025-Q4
KEY TAKEAWAY
Ifosfamide 2025-Q4 exports total $123.1K across 30 countries, with NEOVATUS HEALTH SOLUTIONS PVT LTD commanding 27.9% market share.
TOTAL SHIPMENTS
63
2025-Q4
EXPORT VALUE
$123.1K
FOB USD
TOTAL QUANTITY
45.8K
units shipped
INDIAN SUPPLIERS
33
unique exporters
GLOBAL BUYERS
28
unique importers
DESTINATIONS
30
countries
MEDIAN UNIT PRICE
$4.06
per unit
TOP-5 SHARE
72.4%
of total USD
BRANDED SHARE
57.1%
36 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
NEOVATUS HEALTH SOLUTIONS PVT LTD is India's #1 Ifosfamide exporter with $34.4K (27.9% market share).→ §5, Indian Supplier Rankings
2
Ifosfamide reached 30 countries, with Peru as the top destination ($34.4K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 1435) — top 10 suppliers control 88.9% of exports.→ §5, Indian Supplier Rankings
4
92.9% of buyers (26 of 28) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (89.4%) across 5 dosage forms.→ §7, Price Benchmarks
6
30 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 NEOVATUS HEALTH SOLUTIONS PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian ifosfamide exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Ifosfamide report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial ifosfamide trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian ifosfamide suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Ifosfamide India trade report
Product scope
Ifosfamide
All variants merged — branded and generic formulations of ifosfamide
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
63
Every commercial ifosfamide trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $198, Nov $61.6K, Dec $61.4K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$198
Oct USD
3 shipments
2
$61.6K
Nov USD
+31048.9% MoM
3
$61.4K
Dec USD
-0.3% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 31048.9% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $198, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $123K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $61K rise in Nov, $197 decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $198 | 3 shipments |
| Nov | $62K | 27 shipments |
| Dec | $61K | 33 shipments |
| Q4 Total | $123K | 63 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Afghanistan held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: UNITED BIOTECH PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import ifosfamide from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Peru absorbs 27.9% of India’s 2025-Q4 ifosfamide trade ($34.4K). Beyond the top 10 destinations, 30 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 12 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 30 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much ifosfamide India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$47K
38.2% of trade
12 countries · 23 shipments
Europe
$13K
10.2% of trade
1 countries · 2 shipments
Americas
$46K
37.5% of trade
5 countries · 9 shipments
Africa
$16K
12.7% of trade
11 countries · 28 shipments
Oceania
$2K
1.4% of trade
1 countries · 1 shipments
Fig 4.1 Peru is the #1 corridor ($34K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian ifosfamide it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Peru | $34K | 1 | NEOVATUS HEALTH SOLUTIONS PVT LTD | $34K | — | — | — | — |
| 2 | Lebanon | $20K | 2 | TRIKAYA GLOBAL | $20K | — | — | — | — |
| 3 | Moldova | $13K | 2 | KWALITY PHARMACEUTICALS LTD | $13K | — | — | — | — |
| 4 | Kenya | $9K | 8 | R.S. SURGIPHARM PVT LTD | $8K | 3S CORP | $1K | AMARI TRADE ALLIANCE LLP | $669 |
| 5 | Afghanistan | $8K | 4 | KWALITY PHARMACEUTICALS LTD | $6K | RESCUERS LIFE SCIENCES LTD | $2K | — | — |
| 6 | Bolivia | $8K | 2 | MEDWISE OVERSEAS PVT LTD | $8K | — | — | — | — |
| 7 | Myanmar | $4K | 1 | DOCTIVO LIFESCIENCES PVT LTD | $4K | — | — | — | — |
| 8 | Yemen | $4K | 2 | J.A. UNITED EXPORTS PVT LTD | $4K | — | — | — | — |
| 9 | Venezuela | $3K | 1 | BRIX BIOPHARMA PVT LTD | $3K | — | — | — | — |
| 10 | Nepal | $3K | 5 | UNITED BIOTECH PVT LTD | $3K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 38.2% of USD — but Peru is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
27.9%
#1 country share
Peru alone
69.0%
Top 5 share
5 of 30 countries
96.3%
Top 15 share
Long tail of 15 countries = 3.7%
HHI 1362
Destination HHI
Competitive spread
30
Countries served
Global pharma reach from India
12
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
33 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
NEOVATUS HEALTH SOLUTIONS PVT LTD ($34.4K, 27.9% share) and TRIKAYA GLOBAL ($20.4K) together control 44.5% of India’s 2025-Q4 ifosfamide trade. The top 5 suppliers hold 72.4%. 33 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian ifosfamide suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 NEOVATUS HEALTH SOLUTIONS PVT LTD leads by $14K over TRIKAYA GLOBAL — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SANSKRUTI PHARMA is #15 by value but #2 by volume.
Fig 5.2 UNITED BIOTECH PVT LTD also leads by shipment count (7) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SANSKRUTI PHARMA moves from #2 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 33 ifosfamide suppliers split into strategic segments
KEY TAKEAWAY
9 suppliers (25%) generate 86.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 NEOVATUS HEALTH SOLUTIONS PVT LTD and TRIKAYA GLOBAL sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 86.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | UNITED BIOTECH PVT LTD | 2 | 2 | $6K |
| 2 | NEOVATUS HEALTH SOLUTIONS PVT LTD | 1 | 1 | $34K |
| 3 | TRIKAYA GLOBAL | 1 | 1 | $20K |
| 4 | KWALITY PHARMACEUTICALS LTD | 1 | 2 | $18K |
| 5 | MEDWISE OVERSEAS PVT LTD | 1 | 1 | $8K |
| 6 | R.S. SURGIPHARM PVT LTD | 1 | 1 | $8K |
| 7 | DOCTIVO LIFESCIENCES PVT LTD | 1 | 1 | $4K |
| 8 | J.A. UNITED EXPORTS PVT LTD | 1 | 1 | $4K |
| 9 | M.K.PHARMA | 1 | 1 | $3K |
| 10 | RESCUERS LIFE SCIENCES LTD | 1 | 1 | $2K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the ifosfamide manufacturing hubs
KEY TAKEAWAY
Delhi and Mumbai together account for $53K of India’s 2025-Q4 ifosfamide trade.
Fig 5.5 Delhi (1 exporters, $34K) and Mumbai (12 exporters, $19K) are India’s ifosfamide capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
72.4%
Top 5 share
5 of 33 suppliers
88.9%
Top 10 share
10 of 33 suppliers
86.4%
Top 25% share
9 suppliers = 86% USD
HHI 1435
Supplier HHI
Competitive
33
Total suppliers
shipped Ifosfamide in 2025-Q4
20+ cities
Indian hubs
Delhi and Mumbai lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | UNITED BIOTECH PVT LTD | $6K |
#6
EXPORTER PROFILE #1 OF 1
UNITED BIOTECH PVT LTD
New Delhi · India’s #6 ifosfamide supplier by USD · 2025-Q4
2025-Q4 USD
$6K
4.7% market share
SHIPMENTS
7
avg $828/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
43%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Nepal is the #1 market at $3K (58% of trade), followed by Cambodia at $2K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Nepal | $3K | 5 | 58.2% |
| 2 | Cambodia | $2K | 2 | 41.8% |
MONTHLY TREND
Nov peaked at $3K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 80% of trade. Powder (19.7%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| NIKHIL PHARMA PVT LTD | Nepal | $3K | ⚠ Locked |
| SAK CAM PHARMA CO LTD | Cambodia | $2K | ⚠ Locked |
| Undisclosed buyer | Nepal | $545 | N/A |
#6
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
UNITED BIOTECH PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Nepal absorbs $3K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
28 importers across 30 countries — who is buying Indian ifosfamide and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 65.5% of total USD. 93% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian ifosfamide. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 GRUPO KMEDIC E.I.R.L is the #1 importer at $34K (27.9%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
93%
Single-source
26 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
7%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source ifosfamide from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Kenya 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FOR THE .ORDER OF | 3S CORP | $678.915 | $6.789 | Injection |
| ABU AHMED | AMARI TRADE ALLIANCE… | $669.110 | $6.691 | Powder |
| FOR THE ORDER OF | 3S CORP | $348.167 | $3.482 | Injection |
Afghanistan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TRUST ANESTHETIC LTD | KWALITY PHARMACEUTIC… | $6K | $0.363 | Injection |
| ETEMED MOSLEH LTD | RESCUERS LIFE SCIENC… | $2K | $2.439 | Tablet |
Ghana 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PSG EXPRESS LINK LTD | PREMIER ENTERPRISE | $399.545 | $7.991 | combipack |
| AS PER INVOICE GHANA | VAMA HEALTH WORLD LLP | $9.852 | $0.090 | Injection |
Peru 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| GRUPO KMEDIC E.I.R.L | NEOVATUS HEALTH SOLU… | $34K | $4.300 | Injection |
Lebanon 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AUTOMOBILE TRANSPORTAT… | TRIKAYA GLOBAL | $10K | $5.098 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | GRUPO KMEDIC E.I.R.L | Peru | $34K | $34K | Mid |
| 2 | AUTOMOBILE TRANSPORT… | Lebanon | $10K | $10K | Budget |
| 3 | DITA ESTFARM LLC | Moldova | $6K | $6K | Budget |
| 4 | TRUST ANESTHETIC LTD | Afghanistan | $6K | $3K | Budget |
| 5 | MAGNIFICO SWE MON TO… | Myanmar | $4K | $4K | Budget |
| 6 | AL-NOOR FOR DRUGS & … | Yemen | $4K | $2K | Budget |
| 7 | LLC TIBBI JAHON | Tajikistan | $3K | $3K | Budget |
| 8 | NIKHIL PHARMA PVT LTD | Nepal | $3K | $707.000 | Budget |
| 9 | ETEMED MOSLEH LTD | Afghanistan | $2K | $1K | Budget |
| 10 | SAK CAM PHARMA CO LTD | Cambodia | $2K | $1K | Budget |
| 11 | LUSAKA PHARMACEUTICA… | Zambia | $1K | $1K | Budget |
| 12 | FOR THE .ORDER OF | Kenya | $678.915 | $679.000 | Budget |
| 13 | ABU AHMED | Kenya | $669.110 | $335.000 | Budget |
| 14 | PH.EBENA | Cote d'Ivoire | $608.909 | $609.000 | Budget |
| 15 | PHARMACHEIME LTD | Malawi | $473.360 | $473.000 | Budget |
| 16 | PSG EXPRESS LINK LTD | Ghana | $399.545 | $400.000 | Budget |
| 17 | FOR THE ORDER OF | Kenya | $348.167 | $348.000 | Budget |
| 18 | THE CHIFE PROCUREMEN… | Bhutan | $173.576 | $174.000 | Budget |
| 19 | SALAMA NIGERIA LTD | Benin | $163.467 | $163.000 | Budget |
| 20 | CAMEROON ONCOLOGY CE… | Cameroon | $66.667 | $67.000 | Budget |
| 21 | KINDOS PHARMACEUTICA… | China | $19.818 | $20.000 | Budget |
| 22 | DISTRIBUIDORA MEDICA… | Mexico | $14.214 | $5.000 | Budget |
| 23 | AS PER INVOICE GHANA | Ghana | $9.852 | $5.000 | Budget |
| 24 | MOHAMED AHEMED MOHAMUD | Somalia | $6.200 | $6.000 | Budget |
| 25 | STATE TRADING ORGANI… | Maldives | $4.211 | $4.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 NEOVATUS HEALTH SOLUTIONS PVT LTD → GRUPO KMEDIC E.I.R.L is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian ifosfamide prices vary by supplier, country and dosage form
KEY TAKEAWAY
Ifosfamide prices span 5354× ($0.037 → $198.18). The coefficient of variation is 3.49. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.037 | Lowest observed unit price |
| P5 | $0.048 | 5th percentile |
| P25 | $2.44 | 25th percentile (Q1) |
| Median | $4.06 | 50th percentile (Q2) |
| P75 | $6.18 | 75th percentile (Q3) |
| P95 | $8.02 | 95th percentile |
| Max | $198.18 | Highest observed unit price |
| Mean | $6.98 | Arithmetic average |
| CV | 349% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 PREMIER ENTERPRISE prices at $7.99/unit vs market median $4.06.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. KWALITY PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. NEOVATUS HEALTH SOLUTIONS Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | KEKULE PHARMA LTD | China | — | 0 | $19.82 | $198.18 | Specialty / small-batch |
| Dec 2025 | DM WORLDWIDE TRA… | Cote d'Ivoire | Injection | 5 | $45.38 | $9.08 | Sterile formulation premium |
| Dec 2025 | R.S. SURGIPHARM … | Kenya | Injection | 580 | $5K | $8.03 | Sterile formulation premium |
| Dec 2025 | R.S. SURGIPHARM … | Kenya | Injection | 20 | $160.54 | $8.03 | Sterile formulation premium |
| Nov 2025 | PREMIER ENTERPRISE | Ghana | combipack | 50 | $399.55 | $7.99 | Specialty / small-batch |
| Dec 2025 | BRIX BIOPHARMA P… | Venezuela | — | 450 | $3K | $7.50 | Specialty / small-batch |
| Dec 2025 | 3S CORP | Kenya | Injection | 100 | $678.92 | $6.79 | Sterile formulation premium |
| Dec 2025 | R.S. SURGIPHARM … | Kenya | Injection | 225 | $2K | $6.71 | Sterile formulation premium |
| Dec 2025 | R.S. SURGIPHARM … | Kenya | Injection | 175 | $1K | $6.71 | Sterile formulation premium |
| Nov 2025 | AMARI TRADE ALLI… | Kenya | Powder | 5 | $33.46 | $6.69 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | DISTINCT IMPEX P… | Jamaica | Injection | 30 | $1.11 | $0.037 | Sterile formulation premium |
| Dec 2025 | ATLAS ENTERPRISES | Mexico | Injection | 150 | $7.11 | $0.047 | Sterile formulation premium |
| Dec 2025 | ATLAS ENTERPRISES | Mexico | Injection | 100 | $4.74 | $0.047 | Sterile formulation premium |
| Dec 2025 | ATLAS ENTERPRISES | Mexico | Injection | 50 | $2.37 | $0.047 | Sterile formulation premium |
| Dec 2025 | DISTINCT IMPEX P… | Jamaica | Injection | 1 | $0.049 | $0.049 | Sterile formulation premium |
| Dec 2025 | VAMA HEALTH WORL… | Ghana | Injection | 30 | $1.61 | $0.054 | Sterile formulation premium |
| Dec 2025 | M T MADON EXPORTS | Somalia | Injection | 100 | $6.20 | $0.062 | Sterile formulation premium |
| Dec 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 80 | $5.58 | $0.070 | Sterile formulation premium |
| Dec 2025 | RMPL PHARMA LLP | Turkey | Injection | 30 | $2.14 | $0.071 | Sterile formulation premium |
| Dec 2025 | 3S PHARMACEUTICA… | Zimbabwe | Injection | 50 | $3.62 | $0.072 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship ifosfamide, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Ifosfamide leaves India through 9+ ports. The top 5 (DELHI AIR, MUMBAI AIR (SAHAR), AHMEDABAD AIR) handle 99.8% of total USD. AIR moves 95% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $64K — top 9 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 LIMA - is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 95% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$115K
93.6% of USD · 95.2% of ships
ICD
$4K
3.5% of USD · 1.6% of ships
SEA
$3K
2.7% of USD · 1.6% of ships
ROAD
$174
0.1% of USD · 1.6% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → LatAm ($34K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Burkina Faso is the most concentrated destination (HHI 10000, 1 suppliers). Afghanistan is the most competitive (HHI 5885).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Burkina Faso (HHI 10,000) is the most concentrated — Afghanistan (HHI 5,885) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| GRUPO KMEDIC E.I.R.L | Peru | NEOVATUS HEALTH … | $34K | 1 | MEDIUM |
| AUTOMOBILE TRANSPORT… | Lebanon | TRIKAYA GLOBAL | $10K | 1 | MEDIUM |
| DITA ESTFARM LLC | Moldova | KWALITY PHARMACE… | $6K | 1 | MEDIUM |
| TRUST ANESTHETIC LTD | Afghanistan | KWALITY PHARMACE… | $6K | 2 | MEDIUM |
| MAGNIFICO SWE MON TO… | Myanmar | DOCTIVO LIFESCIE… | $4K | 1 | MEDIUM |
| AL-NOOR FOR DRUGS & … | Yemen | J.A. UNITED EXPO… | $4K | 2 | MEDIUM |
| LLC TIBBI JAHON | Tajikistan | M.K.PHARMA | $3K | 1 | MEDIUM |
| NIKHIL PHARMA PVT LTD | Nepal | UNITED BIOTECH P… | $3K | 4 | MEDIUM |
Conclusion: 26 buyers depend on exactly one Indian supplier, representing $81K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Peru | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Moldova | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Bolivia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Yemen | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tajikistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cambodia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burundi | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Papua New Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Peru | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Burkina Faso lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Peru (1 suppliers) | This Q | HIGH |
| A6 | Enter Lebanon (1 suppliers) | This Q | MED |
| A8 | Build Lebanon distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Peru tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Peru | Other | 1 | $34K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Lebanon | Other | 1 | $20K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Moldova | Other | 1 | $13K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Kenya | Africa | 3 | $9K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 5 | Afghanistan | Asia | 2 | $8K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Bolivia | Other | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Myanmar | Asia | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Yemen | Other | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Venezuela | Other | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Nepal | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Tajikistan | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Cambodia | Asia | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Burundi | Africa | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Papua New Guinea | Other | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Zambia | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 63 2025-Q4 Ifosfamide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ifosfamide
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 63 2025-Q4 ifosfamide shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian ifosfamide shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
63
across all regions
TOTAL USD
$123K
2025-Q4 FOB value
UNITS
45.8K
tablets, capsules, etc.
SUPPLIERS
33
Indian exporters
BUYERS
28
global importers
COUNTRIES
30
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $16K (12.7%), spanning 11 countries.
33 Indian suppliers shipped to 28 buyers across 30 countries — average shipment value $2K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
11 countries · 28 shipments · $16K · 15 Indian suppliers · 14 buyers
SHIPMENTS
28
USD
$16K
COUNTRIES
11
SUPPLIERS
15
BUYERS
14
HHI
2,682
concentrated
Top 11 destination countries in Africa
1
Kenya (58.6%)
$9K
2
Burundi (11.5%)
$2K
3
Zambia (9.4%)
$1K
4
Burkina Faso (9.2%)
$1K
5
Cote d'Ivoire (4.2%)
$654.28
6
Malawi (3.0%)
$473.36
7
Ghana (2.6%)
$409.40
8
Benin (1.0%)
$163.47
9
Cameroon (0.4%)
$66.67
10
Somalia (0.0%)
$6.20
11
Zimbabwe (0.0%)
$3.62
Top 15 Indian suppliers into Africa
1
R.S. SURGIPHARM PVT LTD
$8K
2
VEA IMPEX (I) PVT LTD
$2K
3
PATSONS INTERNATIONAL
$1K
4
SANSKRUTI PHARMA
$1K
5
3S CORP
$1K
6
AMARI TRADE ALLIANCE LLP
$669.11
7
SAMEEKSHA PHARMACEUTICALS PVT LTD
$608.91
8
MATHI ASSOCIATES
$473.36
9
PREMIER ENTERPRISE
$399.55
10
ZAHIDI ENTERPRISE
$163.47
11
SUDDHASATTWA RAY
$66.67
12
DM WORLDWIDE TRADING
$45.38
13
VAMA HEALTH WORLD LLP
$9.85
14
M T MADON EXPORTS
$6.20
15
3S PHARMACEUTICALS INDIA PVT LTD
$3.62
Top 12 Africa importers
1
LUSAKA PHARMACEUTICALS LTD · Zambia
$1K
2
FOR THE .ORDER OF · Kenya
$678.92
3
ABU AHMED · Kenya
$669.11
4
PH.EBENA · Cote d'Ivoire
$608.91
5
PHARMACHEIME LTD · Malawi
$473.36
6
PSG EXPRESS LINK LTD · Ghana
$399.55
7
FOR THE ORDER OF · Kenya
$348.17
8
SALAMA NIGERIA LTD · Benin
$163.47
9
CAMEROON ONCOLOGY CENTRE IN DOUALA · Cameroon
$66.67
10
AS PER INVOICE GHANA · Ghana
$9.85
11
MOHAMED AHEMED MOHAMUD · Somalia
$6.20
12
FOR THE ORDER OF* · Zimbabwe
$3.62
Top 4 dosage forms
1
Injection
$13K
2
Vial
$2K
3
Powder
$669.11
4
combipack
$399.55
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 11 | $5K | $442.21 |
| Dec | 17 | $11K | $637.13 |
Shipment register · 28 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — R.S. SURGIPHARM PVT LTD · 4 shipments · $8K | |||||||||||
| 1 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 175 | VLS | $6.71 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 2 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 225 | VLS | $6.71 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 3 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 580 | VLS | $8.03 | $5K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 4 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 20 | VLS | $8.03 | $160.54 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #2 — VEA IMPEX (I) PVT LTD · 4 shipments · $2K | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 120 | NOS | $4.52 | $542.19 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 6 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 80 | NOS | $4.52 | $361.47 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 7 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 120 | NOS | $4.52 | $542.19 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 8 | Dec 2025 | UNLISTED BUYER | Burundi | Vial | 80 | NOS | $4.52 | $361.47 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #3 — PATSONS INTERNATIONAL · 1 shipments · $1K | |||||||||||
| 9 | Nov 2025 | LUSAKA PHARMACEUTICALS LTD | Zambia | Injection | 300 | NOS | $4.91 | $1K | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #4 — SANSKRUTI PHARMA · 5 shipments · $1K | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 50 | VLS | $6.43 | $321.63 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 11 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 50 | VLS | $6.18 | $309.25 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 12 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 50 | VLS | $6.18 | $309.25 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 13 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 80 | VLS | $6.18 | $494.75 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 80 | VLS | $0.070 | $5.58 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #5 — 3S CORP · 2 shipments · $1K | |||||||||||
| 15 | Nov 2025 | FOR THE ORDER OF | Kenya | Injection | 100 | VLS | $3.48 | $348.17 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 16 | Dec 2025 | FOR THE .ORDER OF | Kenya | Injection | 100 | VLS | $6.79 | $678.92 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #6 — AMARI TRADE ALLIANCE LLP · 2 shipments · $669.11 | |||||||||||
| 17 | Nov 2025 | ABU AHMED | Kenya | Powder | 95 | VLS | $6.69 | $635.65 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 18 | Nov 2025 | ABU AHMED | Kenya | Powder | 5 | VLS | $6.69 | $33.46 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #7 — SAMEEKSHA PHARMACEUTICALS PVT LTD · 1 shipments · $608.91 | |||||||||||
| 19 | Dec 2025 | PH.EBENA | Cote d'Ivoire | Injection | 150 | NOS | $4.06 | $608.91 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| SUPPLIER #8 — MATHI ASSOCIATES · 1 shipments · $473.36 | |||||||||||
| 20 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 100 | VLS | $4.73 | $473.36 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #9 — PREMIER ENTERPRISE · 1 shipments · $399.55 | |||||||||||
| 21 | Nov 2025 | PSG EXPRESS LINK LTD | Ghana | combipack | 50 | NOS | $7.99 | $399.55 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #10 — ZAHIDI ENTERPRISE · 1 shipments · $163.47 | |||||||||||
| 22 | Dec 2025 | SALAMA NIGERIA LTD | Benin | Injection | 50 | NOS | $3.27 | $163.47 | MUMBAI AIR (SAHAR) | COTONOU | AIR |
| SUPPLIER #11 — SUDDHASATTWA RAY · 1 shipments · $66.67 | |||||||||||
| 23 | Nov 2025 | CAMEROON ONCOLOGY CENTRE IN DOUALA | Cameroon | Injection | 20 | PCS | $3.33 | $66.67 | KOLKATA AIR | DOUALA | AIR |
| SUPPLIER #12 — DM WORLDWIDE TRADING · 1 shipments · $45.38 | |||||||||||
| 24 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 5 | NOS | $9.08 | $45.38 | AHMEDABAD AIR | ABIDJAN | AIR |
| SUPPLIER #13 — VAMA HEALTH WORLD LLP · 2 shipments · $9.85 | |||||||||||
| 25 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 80 | NOS | $0.103 | $8.25 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 26 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 30 | NOS | $0.054 | $1.61 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #14 — M T MADON EXPORTS · 1 shipments · $6.20 | |||||||||||
| 27 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Injection | 100 | NOS | $0.062 | $6.20 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #15 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $3.62 | |||||||||||
| 28 | Dec 2025 | FOR THE ORDER OF* | Zimbabwe | Injection | 50 | NOS | $0.072 | $3.62 | MUMBAI AIR (SAHAR) | HARARE | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
12 countries · 23 shipments · $47K · 12 Indian suppliers · 13 buyers
SHIPMENTS
23
USD
$47K
COUNTRIES
12
SUPPLIERS
12
BUYERS
13
HHI
2,419
moderate
Top 12 destination countries in Asia
1
Lebanon (43.4%)
$20K
2
Afghanistan (17.9%)
$8K
3
Myanmar (9.3%)
$4K
4
Yemen (7.7%)
$4K
5
Nepal (7.2%)
$3K
6
Tajikistan (6.5%)
$3K
7
Cambodia (5.2%)
$2K
8
Turkey (2.1%)
$974.54
9
Bhutan (0.4%)
$173.58
10
Azerbaijan (0.3%)
$157.41
11
China (0.0%)
$19.82
12
Maldives (0.0%)
$4.21
Top 12 Indian suppliers into Asia
1
TRIKAYA GLOBAL
$20K
2
KWALITY PHARMACEUTICALS LTD
$6K
3
UNITED BIOTECH PVT LTD
$6K
4
DOCTIVO LIFESCIENCES PVT LTD
$4K
5
J.A. UNITED EXPORTS PVT LTD
$4K
6
M.K.PHARMA
$3K
7
RESCUERS LIFE SCIENCES LTD
$2K
8
RMPL PHARMA LLP
$974.54
9
FLORENCE INDIA
$173.58
10
MELON GLOBALCARE
$157.41
11
KEKULE PHARMA LTD
$19.82
12
MC PHARMA DISTRIBUTORS
$4.21
Top 11 Asia importers
1
AUTOMOBILE TRANSPORTATION SERVICES · Lebanon
$10K
2
TRUST ANESTHETIC LTD · Afghanistan
$6K
3
MAGNIFICO SWE MON TOE CO LTD · Myanmar
$4K
4
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$4K
5
LLC TIBBI JAHON · Tajikistan
$3K
6
NIKHIL PHARMA PVT LTD · Nepal
$3K
7
ETEMED MOSLEH LTD · Afghanistan
$2K
8
SAK CAM PHARMA CO LTD · Cambodia
$2K
9
THE CHIFE PROCUREMENT OFFICER · Bhutan
$173.58
10
KINDOS PHARMACEUTICALS CO LTD · China
$19.82
11
STATE TRADING ORGANIZATION PLC · Maldives
$4.21
Top 5 dosage forms
1
Injection
$40K
2
Vial
$3K
3
Tablet
$2K
4
Powder
$1K
5
Unknown
$19.82
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $197.61 | $65.87 |
| Nov | 12 | $36K | $3K |
| Dec | 8 | $11K | $1K |
Shipment register · 23 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — TRIKAYA GLOBAL · 2 shipments · $20K | |||||||||||
| 1 | Nov 2025 | AUTOMOBILE TRANSPORTATION SERVICES | Lebanon | Injection | 2.0K | VLS | $5.10 | $10K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Lebanon | Injection | 2.0K | VLS | $5.10 | $10K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #2 — KWALITY PHARMACEUTICALS LTD · 2 shipments · $6K | |||||||||||
| 3 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 1.5K | NOS | $2.30 | $3K | DELHI AIR | KABUL | AIR |
| 4 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 15.0K | NOS | $0.169 | $3K | DELHI AIR | KABUL | AIR |
| SUPPLIER #3 — UNITED BIOTECH PVT LTD · 7 shipments · $6K | |||||||||||
| 5 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 200 | PCS | $2.73 | $545.21 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Nepal | Injection | 200 | PCS | $2.73 | $545.21 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 7 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Powder | 200 | PCS | $5.71 | $1K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 8 | Nov 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 300 | VLS | $4.00 | $1K | DELHI AIR | PHNOM PENH - POCHENT | AIR |
| 9 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 100 | PCS | $2.71 | $271.30 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 10 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 150 | PCS | $5.79 | $868.59 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 11 | Dec 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 300 | VLS | $4.08 | $1K | DELHI AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #4 — DOCTIVO LIFESCIENCES PVT LTD · 1 shipments · $4K | |||||||||||
| 12 | Dec 2025 | MAGNIFICO SWE MON TOE CO LTD | Myanmar | Injection | 700 | NOS | $6.22 | $4K | TUGHLAKABAD ICD | Yangon | ICD |
| SUPPLIER #5 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $4K | |||||||||||
| 13 | Nov 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 500 | NOS | $3.60 | $2K | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 14 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 500 | NOS | $3.65 | $2K | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #6 — M.K.PHARMA · 1 shipments · $3K | |||||||||||
| 15 | Nov 2025 | LLC TIBBI JAHON | Tajikistan | Vial | 1.0K | PCS | $3.05 | $3K | DELHI AIR | DUSHANBE | AIR |
| SUPPLIER #7 — RESCUERS LIFE SCIENCES LTD · 2 shipments · $2K | |||||||||||
| 16 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 500 | NOS | $2.44 | $1K | DELHI AIR | KABUL | AIR |
| 17 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 500 | NOS | $2.44 | $1K | DELHI AIR | KABUL | AIR |
| SUPPLIER #8 — RMPL PHARMA LLP · 2 shipments · $974.54 | |||||||||||
| 18 | Nov 2025 | UNLISTED BUYER | Turkey | Injection | 150 | NOS | $6.48 | $972.40 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 30 | NOS | $0.071 | $2.14 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #9 — FLORENCE INDIA · 1 shipments · $173.58 | |||||||||||
| 20 | Oct 2025 | THE CHIFE PROCUREMENT OFFICER | Bhutan | Powder | 60 | NOS | $2.89 | $173.58 | JAIGAON LCS | PHUNTSHOLING | ROAD |
| SUPPLIER #10 — MELON GLOBALCARE · 1 shipments · $157.41 | |||||||||||
| 21 | Nov 2025 | UNLISTED BUYER | Azerbaijan | Injection | 50 | NOS | $3.15 | $157.41 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #11 — KEKULE PHARMA LTD · 1 shipments · $19.82 | |||||||||||
| 22 | Oct 2025 | KINDOS PHARMACEUTICALS CO LTD | China | 0 | KGS | $198.18 | $19.82 | HYDERABAD AIR | SHANGHAI - PU DONG | AIR | |
| SUPPLIER #12 — MC PHARMA DISTRIBUTORS · 1 shipments · $4.21 | |||||||||||
| 23 | Oct 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Injection | 1 | NOS | $4.21 | $4.21 | CHENNAI AIR | MALE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 2 shipments · $13K · 1 Indian suppliers · 2 buyers
SHIPMENTS
2
USD
$13K
COUNTRIES
1
SUPPLIERS
1
BUYERS
2
HHI
10,000
concentrated
Top 1 destination countries in Europe
1
Moldova (100.0%)
$13K
Top 1 Indian suppliers into Europe
1
KWALITY PHARMACEUTICALS LTD
$13K
Top 1 Europe importers
1
DITA ESTFARM LLC · Moldova
$6K
Top 1 dosage forms
1
Injection
$13K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $13K | $6K |
| Dec | 0 | $0.0000 | — |
Shipment register · 2 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KWALITY PHARMACEUTICALS LTD · 2 shipments · $13K | |||||||||||
| 1 | Nov 2025 | DITA ESTFARM LLC | Moldova | Injection | 2.7K | NOS | $2.32 | $6K | DELHI AIR | CHISINAU | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Moldova | Injection | 2.7K | NOS | $2.32 | $6K | DELHI AIR | CHISINAU | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 9 shipments · $46K · 5 Indian suppliers · 4 buyers
SHIPMENTS
9
USD
$46K
COUNTRIES
5
SUPPLIERS
5
BUYERS
4
HHI
5,930
concentrated
Top 5 destination countries in Americas
1
Peru (74.5%)
$34K
2
Bolivia (18.2%)
$8K
3
Venezuela (7.3%)
$3K
4
Mexico (0.0%)
$14.21
5
Jamaica (0.0%)
$1.16
Top 5 Indian suppliers into Americas
1
NEOVATUS HEALTH SOLUTIONS PVT LTD
$34K
2
MEDWISE OVERSEAS PVT LTD
$8K
3
BRIX BIOPHARMA PVT LTD
$3K
4
ATLAS ENTERPRISES
$14.21
5
DISTINCT IMPEX PVT LTD
$1.16
Top 2 Americas importers
1
GRUPO KMEDIC E.I.R.L · Peru
$34K
2
DISTRIBUIDORA MEDICA PAREDES S.DE R · Mexico
$14.21
Top 2 dosage forms
1
Injection
$43K
2
Unknown
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $8K | $4K |
| Dec | 7 | $38K | $5K |
Shipment register · 9 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NEOVATUS HEALTH SOLUTIONS PVT LTD · 1 shipments · $34K | |||||||||||
| 1 | Dec 2025 | GRUPO KMEDIC E.I.R.L | Peru | Injection | 8.0K | NOS | $4.30 | $34K | DELHI AIR | LIMA - | AIR |
| SUPPLIER #2 — MEDWISE OVERSEAS PVT LTD · 2 shipments · $8K | |||||||||||
| 2 | Nov 2025 | UNKNOWN BUYER | Bolivia | Injection | 1.5K | NOS | $3.39 | $5K | AHMEDABAD AIR | LAPAZ | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Bolivia | Injection | 990 | NOS | $3.39 | $3K | AHMEDABAD AIR | LAPAZ | AIR |
| SUPPLIER #3 — BRIX BIOPHARMA PVT LTD · 1 shipments · $3K | |||||||||||
| 4 | Dec 2025 | UNKNOWN BUYER | Venezuela | 450 | NOS | $7.50 | $3K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA | |
| SUPPLIER #4 — ATLAS ENTERPRISES · 3 shipments · $14.21 | |||||||||||
| 5 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 150 | NOS | $0.047 | $7.11 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 6 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 100 | NOS | $0.047 | $4.74 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 7 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 50 | NOS | $0.047 | $2.37 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #5 — DISTINCT IMPEX PVT LTD · 2 shipments · $1.16 | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Jamaica | Injection | 1 | NOS | $0.049 | $0.049 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 9 | Dec 2025 | UNLISTED BUYER | Jamaica | Injection | 30 | NOS | $0.037 | $1.11 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $2K · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$2K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$2K
Top 1 Indian suppliers into Oceania
1
BRUCK PHARMA PVT LTD
$2K
Top 0 Oceania importers
Top 1 dosage forms
1
Injection
$2K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $2K | $2K |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRUCK PHARMA PVT LTD · 1 shipments · $2K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Injection | 300 | NOS | $5.82 | $2K | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 33 Indian ifosfamide exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped ifosfamide in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | NEOVATUS HEALTH SOLUTIONS PVT LTD | DELHI | 1 | $34K | Injection | Americas |
| 2 | TRIKAYA GLOBAL | MUMBAI | 2 | $20K | Injection | Asia |
| 3 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 4 | $18K | Injection | Europe, Asia |
| 4 | MEDWISE OVERSEAS PVT LTD | AHMEDABAD | 2 | $8K | Injection | Americas |
| 5 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 4 | $8K | Injection | Africa |
| 6 | UNITED BIOTECH PVT LTD | NEW DELHI | 7 | $6K | Injection, Powder | Asia |
| 7 | DOCTIVO LIFESCIENCES PVT LTD | Faridabad | 1 | $4K | Injection | Asia |
| 8 | J.A. UNITED EXPORTS PVT LTD | VASHI | 2 | $4K | Injection | Asia |
| 9 | BRIX BIOPHARMA PVT LTD | MUMBAI | 1 | $3K | Americas | |
| 10 | M.K.PHARMA | BHAWANI MANDI | 1 | $3K | Vial | Asia |
| 11 | RESCUERS LIFE SCIENCES LTD | NALAGARH ROAD BADDI | 2 | $2K | Tablet | Asia |
| 12 | VEA IMPEX (I) PVT LTD | MUMBAI | 4 | $2K | Vial | Africa |
| 13 | BRUCK PHARMA PVT LTD | NANI | 1 | $2K | Injection | Oceania |
| 14 | PATSONS INTERNATIONAL | ANAND | 1 | $1K | Injection | Africa |
| 15 | SANSKRUTI PHARMA | SURAT | 5 | $1K | Injection | Africa |
| 16 | 3S CORP | MUMBAI | 2 | $1K | Injection | Africa |
| 17 | RMPL PHARMA LLP | MUMBAI | 2 | $974.54 | Injection | Asia |
| 18 | AMARI TRADE ALLIANCE LLP | MUMBAI | 2 | $669.11 | Powder | Africa |
| 19 | SAMEEKSHA PHARMACEUTICALS PVT LTD | PUNE | 1 | $608.91 | Injection | Africa |
| 20 | MATHI ASSOCIATES | MUMBAI | 1 | $473.36 | Injection | Africa |
| 21 | PREMIER ENTERPRISE | NAGPUR | 1 | $399.55 | combipack | Africa |
| 22 | FLORENCE INDIA | KOLKATA | 1 | $173.58 | Powder | Asia |
| 23 | ZAHIDI ENTERPRISE | CHINCHBUNDER | 1 | $163.47 | Injection | Africa |
| 24 | MELON GLOBALCARE | MUMBAI | 1 | $157.41 | Injection | Asia |
| 25 | SUDDHASATTWA RAY | BHOWANIPORE KOLKATA | 1 | $66.67 | Injection | Africa |
| 26 | DM WORLDWIDE TRADING | MAHESANA | 1 | $45.38 | Injection | Africa |
| 27 | KEKULE PHARMA LTD | HYDERABAD | 1 | $19.82 | Asia | |
| 28 | ATLAS ENTERPRISES | NAGPUR | 3 | $14.21 | Injection | Americas |
| 29 | VAMA HEALTH WORLD LLP | Mumbai | 2 | $9.85 | Injection | Africa |
| 30 | M T MADON EXPORTS | MUMBAI | 1 | $6.20 | Injection | Africa |
| 31 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $4.21 | Injection | Asia |
| 32 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 1 | $3.62 | Injection | Africa |
| 33 | DISTINCT IMPEX PVT LTD | MUMBAI | 2 | $1.16 | Injection | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 26 global ifosfamide importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian ifosfamide in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | GRUPO KMEDIC E.I.R.L | Peru | 1 | $34K | NEOVATUS HEALTH SOLU… | Injection |
| 2 | AUTOMOBILE TRANSPORTATION SERVICES | Lebanon | 1 | $10K | TRIKAYA GLOBAL | Injection |
| 3 | DITA ESTFARM LLC | Moldova | 1 | $6K | KWALITY PHARMACEUTIC… | Injection |
| 4 | TRUST ANESTHETIC LTD | Afghanistan | 2 | $6K | KWALITY PHARMACEUTIC… | Injection |
| 5 | MAGNIFICO SWE MON TOE CO LTD | Myanmar | 1 | $4K | DOCTIVO LIFESCIENCES… | Injection |
| 6 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 2 | $4K | J.A. UNITED EXPORTS … | Injection |
| 7 | LLC TIBBI JAHON | Tajikistan | 1 | $3K | M.K.PHARMA | Vial |
| 8 | NIKHIL PHARMA PVT LTD | Nepal | 4 | $3K | UNITED BIOTECH PVT LTD | Injection, Powder |
| 9 | ETEMED MOSLEH LTD | Afghanistan | 2 | $2K | RESCUERS LIFE SCIENC… | Tablet |
| 10 | SAK CAM PHARMA CO LTD | Cambodia | 2 | $2K | UNITED BIOTECH PVT LTD | Injection |
| 11 | LUSAKA PHARMACEUTICALS LTD | Zambia | 1 | $1K | PATSONS INTERNATIONAL | Injection |
| 12 | FOR THE .ORDER OF | Kenya | 1 | $678.92 | 3S CORP | Injection |
| 13 | ABU AHMED | Kenya | 2 | $669.11 | AMARI TRADE ALLIANCE… | Powder |
| 14 | PH.EBENA | Cote d'Ivoire | 1 | $608.91 | SAMEEKSHA PHARMACEUT… | Injection |
| 15 | PHARMACHEIME LTD | Malawi | 1 | $473.36 | MATHI ASSOCIATES | Injection |
| 16 | PSG EXPRESS LINK LTD | Ghana | 1 | $399.55 | PREMIER ENTERPRISE | combipack |
| 17 | FOR THE ORDER OF | Kenya | 1 | $348.17 | 3S CORP | Injection |
| 18 | THE CHIFE PROCUREMENT OFFICER | Bhutan | 1 | $173.58 | FLORENCE INDIA | Powder |
| 19 | SALAMA NIGERIA LTD | Benin | 1 | $163.47 | ZAHIDI ENTERPRISE | Injection |
| 20 | CAMEROON ONCOLOGY CENTRE IN DOUALA | Cameroon | 1 | $66.67 | SUDDHASATTWA RAY | Injection |
| 21 | KINDOS PHARMACEUTICALS CO LTD | China | 1 | $19.82 | KEKULE PHARMA LTD | |
| 22 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | 3 | $14.21 | ATLAS ENTERPRISES | Injection |
| 23 | AS PER INVOICE GHANA | Ghana | 2 | $9.85 | VAMA HEALTH WORLD LLP | Injection |
| 24 | MOHAMED AHEMED MOHAMUD | Somalia | 1 | $6.20 | M T MADON EXPORTS | Injection |
| 25 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $4.21 | MC PHARMA DISTRIBUTORS | Injection |
| 26 | FOR THE ORDER OF* | Zimbabwe | 1 | $3.62 | 3S PHARMACEUTICALS I… | Injection |
This report covers 63 2025-Q4 Ifosfamide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ifosfamide
Talk to our trade analyst
Need a custom ifosfamide report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/ifosfamide
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Ifosfamide product page
Live data, supplier directory, price trends, and trade route analysis